|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study显示文摘 | Thomas J. Lynch Igor Bondarenko Alexander Luft Piotr Serwatowski Fabrice Barlesi Raju Chacko Martin Sebastian Joel Neal Haolan Lu Jean-Marie Cuillerot Martin Reck | 2012 | Journal of Clinical Oncology2012，，17： | 2 |
| 2 | Video-assisted ehoracoscopic management of recurrent primary spontaneous pneumothorax after prior talc pleurodesis:a Peasible,safe and efficient treatment option显示文摘 | Doddli C Barlesi F Raticelli A | 2004 | Eur J Card Thorac Surg2004，26，5： | 1 |
| 3 | Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase Ⅲ rando- mized trials 显示文摘 | Pujol JL Barlesi F Daures JP | 2006 | Lung Cancer2006，51，3： | 1 |
| 4 | Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer显示文摘 | David R. Spigel Thomas J. Ervin Rodryg A. Ramlau Davey B. Daniel Jerome H. Goldschmidt George R. Blumenschein Maciej J. Krzakowski Gilles Robinet Benoit Godbert Fabrice Barlesi Ramaswamy Govindan Taral Patel Sergey V. Orlov Michael S. Wertheim Wei Yu Jipi | 2013 | Journal of Clinical Oncology2013，，32： | 1 |
| 5 | CYFRA 21-1 level pre- dicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy显示文摘 | Barlesi F Tchouhadjian C Doddoli C | 2005 | Br J Cancer2005，92，1： | 1 |
| 6 | Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase Ⅲ trials显示文摘 | Barlesi F Pujol JL | 2005 | Lung Cancer2005，49，3： | 1 |
| 7 | Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer:a systematic review of phase Ⅲ trials显示文摘 | Barlesi F Pujol JL | 2005 | Lung Cancer2005，49，3： | 1 |
| 8 | Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study显示文摘 | Thomas J. Lynch Igor Bondarenko Alexander Luft Piotr Serwatowski Fabrice Barlesi Raju Chacko Martin Sebastian Joel Neal Haolan Lu Jean-Marie Cuillerot Martin Reck | 2012 | Journal of Clinical Oncology2012，，17： | 1 |
| 9 | Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)显示文摘 | Vansteenkiste J Barlesi F Waller CF | 2015 | Ann Oncol2015，26，8： | 1 |
| 10 | Maintenance bevacizumab - pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsqua- mous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase m trial 显示文摘 | Barlesi F Scherpereel A Gorbunova V | 2014 | Ann Oncol2014，25，5： | 1 |
| 11 | Neurocognitive func- tion impairment after whole brain radiotherapy for brain me- tastases: actual assessment显示文摘 | Tallet AV Azria D Barlesi F | 2012 | Radiat Oncol2012，7，1： | 1 |
| 12 | Second line therapy with gefitinib in combination with doeetaxel for advanced non-small cell lung cancer: a phase Ⅱ randomized study显示文摘 | Robinet G Barlesi F Fournel P | 2007 | Targ Oncoh2007，2，2： | 1 |
| 13 | Translational Research: Precision Medicine, Personalized Medicine,Targeted Therapies: Marketing or Science?显示文摘 | Marquet P Longeray PH Barlesi F | 2015 | Thérapie2015，70，1： | 1 |
| 14 | Gemcitabine-induced severe pulmonary toxicity 显示文摘 | Villani P Doddoli C | 2004 | Fundam Clin Pharmacol2004，18，1： | 1 |
| 15 | Neurocognitive function impairment after whole brain radiotherapy for brain metastases:actual assessment显示文摘 | Tallet AV Azria D Barlesi F | 2012 | Radiat Oncol2012，7，： | 1 |
| 16 | Prognostic value of combination of CYFRA21-1,CEA and NSE in patients with advanced non-small cell lung cancer显示文摘 | Fabrice Barlesi Celine Gimenez Jean-Philippe Torre | 2004 | Respir Med2004，98，： | 1 |
| 17 | Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer显示文摘 | Doddoli C Aragon A Barlesi F | | 0，，04： | 1 |
| 18 | Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer 显示文摘 | Barlesi F Gimenez C Torre JP | 2004 | Respir Med2004，98，4： | 1 |
| 19 | Targeted therapies in malignant pleural mesothelioma:a review of clinical studies显示文摘 | Greillier L Marco S Barlesi F | 2011 | Anticaneer Drugs2011，22，3： | 1 |
| 20 | Prognostic value of combination of Cyfra21-1, CEA and NSE in patients with advanced non-small cell lung cancer 显示文摘 | Barlesi F Gimenez C Torte JP | 2004 | Respir ned2004，98，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员